| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 74.594.890 | 73.910.258 | 78.501.126 | 82.321.099 | 70.506.640 | 74.476.795 | 98.088.652 | 121.455.741 | 135.699.691 |
| Total Income - EUR | - | 76.841.531 | 76.578.214 | 80.993.305 | 85.931.755 | 78.640.760 | 78.621.555 | 105.896.179 | 129.531.375 | 139.312.818 |
| Total Expenses - EUR | - | 69.074.175 | 68.542.212 | 73.453.043 | 78.518.283 | 72.784.057 | 72.495.855 | 97.399.124 | 111.028.546 | 118.583.758 |
| Gross Profit/Loss - EUR | - | 7.767.357 | 8.036.002 | 7.540.262 | 7.413.473 | 5.856.703 | 6.125.701 | 8.497.056 | 18.502.829 | 20.729.060 |
| Net Profit/Loss - EUR | - | 6.762.895 | 7.346.239 | 7.371.610 | 6.495.401 | 5.455.345 | 6.052.277 | 7.809.678 | 16.393.126 | 20.546.173 |
| Employees | - | 1.449 | 1.420 | 1.415 | 1.415 | 1.415 | 1.410 | 1.355 | 1.352 | 1.350 |
Check the financial reports for the company - Antibiotice Sa
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 48.316.350 | 52.423.536 | 73.387.238 | 80.696.370 | 100.905.692 | 103.315.139 | 108.181.028 | 149.256.805 | 164.343.854 |
| Current Assets | - | 70.095.598 | 72.556.093 | 77.946.778 | 86.254.845 | 77.162.632 | 77.229.959 | 64.835.519 | 80.336.370 | 92.009.450 |
| Inventories | - | 13.420.683 | 14.757.731 | 14.221.878 | 15.620.010 | 22.475.844 | 21.455.947 | 24.913.227 | 32.677.585 | 34.255.189 |
| Receivables | - | 53.579.100 | 56.680.229 | 63.214.170 | 70.239.208 | 53.378.265 | 55.347.196 | 39.572.003 | 47.293.288 | 57.215.222 |
| Cash | - | 3.095.815 | 1.118.133 | 510.730 | 395.627 | 1.308.523 | 426.817 | 350.290 | 365.497 | 539.039 |
| Shareholders Funds | - | 91.089.863 | 91.258.475 | 101.585.326 | 104.699.902 | 119.342.591 | 122.299.628 | 130.068.053 | 171.224.931 | 179.785.864 |
| Social Capital | - | 58.211.335 | 57.325.111 | 54.722.763 | 14.147.133 | 13.878.937 | 13.571.158 | 13.613.262 | 13.571.981 | 13.496.131 |
| Debts | - | 26.137.913 | 32.540.070 | 48.405.034 | 60.467.823 | 55.699.901 | 57.426.318 | 41.813.016 | 55.381.092 | 73.930.665 |
| Income in Advance | - | 648.970 | 618.449 | 671.924 | 648.874 | 573.253 | 498.623 | 438.733 | 382.635 | 1.138.374 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2110 - 2110" | |||||||||
| CAEN Financial Year |
2110
|
|||||||||
Comments - Antibiotice Sa